Sign in
TerminatedPhase 4

Mindfulness Based Smoking Cessation Among Cancer Survivors

Key facts

Who runs it
University of Miami
Where
Memphis and Miami, United StatesSee the 2 sites
Trial code
Status
Terminated
Phase
Phase 4
People taking part
20 people enrolled
Started
28 Sept 2019
Ended
19 May 2024
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Nicoderm C-Q Transdermal Product
  • Orientation session
  • Craving-to-Quit app
  • Two brief follow-up phone calls
  • Group MT sessions
  • Brief advice on quitting smoking
  • Self-help smoking cessation materials
Record updated
9 September 2025
Why it stopped
Recruitment for the study proved to be a significant challenge, raising important concerns about its overall feasibility.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Be 18 years and older
  • Cancer survivors (based on the NCI definition - "a person is considered to be a survivor from the time of diagnosis until the end of life" National Cancer Institute Dictionary of Cancer Terms, 2014)
  • Cancer patients currently in active treatment
  • Have smoked ≥ 5 cigarettes/day in the past year
  • Be interested in making a quit attempt in the next 30 days
  • Own a smartphone (apple/android)
  • Read/speak English
  • Able to consent
  • Have no plans to move in the next 3 months
  • Are not pregnant or planning to be pregnant in the following 3 months

Who cannot take part

  • Are currently being treated for smoking cessation, alcoholism, or illicit drug use
  • Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder)
  • Are currently being treated for a psychiatric condition
  • Are adults unable to consent
  • Are individuals who are not yet adults
  • Are pregnant women
  • Are prisoners

Where in United States

  • St. Jude Children's Research HospitalMemphis, United States
  • University of MiamiMiami, United States

About the trial

What the trial wants to find out

This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.

The 3 groups in the trial

  • Usual CareExisting treatment, for comparison

    Participants in this group will receive a brief advice to quit smoking, 6-week supplies of nicotine replacement therapy (NRT), and self-help materials to quit smoking.

    Treatment: Nicoderm C-Q Transdermal Product, Brief advice on quitting smoking, and Self-help smoking cessation materials

  • Craving-to-Quit appTreatment being tested

    Participants in this group will receive one "in-person" or online orientation session, 6-week supply of NRT, the "Craving-to-Quit" app, and two brief follow-up phone calls.

    Treatment: Nicoderm C-Q Transdermal Product, Orientation session, Craving-to-Quit app, and Two brief follow-up phone calls

  • Group Mindfulness TrainingTreatment being tested

    Participants in this group will receive twice weekly group sessions (eight total during 4 weeks) that were manualized and delivered by instructors experienced in Mindfulness Training (MT) (a single therapist with \>4 years of training in MT).

    Treatment: Nicoderm C-Q Transdermal Product, Orientation session, and Group MT sessions

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Smartphone Application Versus Group Mindfulness-based Smoking Cessation Intervention for Cancer Patients and Survivors: Reach Versus Effectiveness
Record updated
9 September 2025